Corticosteroid administration and glycemic outcomes during treatment of acute exacerbation of chronic obstructive pulmonary disease
Authors:
- Herman Joseph JohannesmeyerHJHerman Joseph Johannesmeyer
- Kayvan MoussaviKMKayvan Moussavi
- Kerry Anne RambaranKRKerry Anne Rambaran
- Kristica KolyouthapongKKKristica Kolyouthapong
Open Access
- 7 November 2022
- journal article
- research article
- Published by Elsevier in American Journal of Medicine Open
- Vol. 8
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Short-term vs Conventional Glucocorticoid Therapy in Acute Exacerbations of Chronic Obstructive Pulmonary DiseaseJAMA, 2013
- Impact of hospitalisations for exacerbations of COPD on health-related quality of lifeRespiratory Medicine, 2009
- Inhaled and Systemic Corticosteroids in Chronic Obstructive Pulmonary DiseaseProceedings of the American Thoracic Society, 2008
- Interactions between Corticosteroids and β2-Agonists in Asthma and Chronic Obstructive Pulmonary DiseaseProceedings of the American Thoracic Society, 2004
- Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up studyThorax, 2004
- Outpatient Oral Prednisone after Emergency Treatment of Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2003
- Effect of Systemic Glucocorticoids on Exacerbations of Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 1999
- Effect of Exacerbation on Quality of Life in Patients with Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Controlled Trial of Oral Prednisone in Outpatients With Acute COPD ExacerbationAmerican Journal of Respiratory and Critical Care Medicine, 1996
- A New Simplified Acute Physiology Score (SAPS II) Based on a European/North American Multicenter StudyJAMA, 1993